Prosecution Insights
Last updated: April 19, 2026

BAILI-BIO (CHENGDU) PHARMACEUTICAL CO., LTD.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
0
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18030757 Deuterated Camptothecin Derivative And Antibody-drug Conjugate Thereof PATEL, SAGAR S 1626 Non-Final OA Apr 06, 2023
18027583 EGFR BINDING COMPLEX AND METHOD OF MAKING AND USING THEREOF BRISTOL, LYNN ANNE 1643 Non-Final OA Mar 21, 2023
17909358 GUIDANCE AND NAVIGATION CONTROL (GNC) ANTIBODY-LIKE PROTEINSAND METHODS OF MAKING AND USING THEREOF DRISCOLL, MAUREEN VARINA 1644 Non-Final OA Sep 02, 2022
17772464 RECOMBINANT ACE2-FC FUSION MOLECULES AND METHODS OF MAKING AND USING THEREOF EDWARDS, JESSICA FAYE 1657 Non-Final OA Apr 27, 2022

Managing BAILI-BIO (CHENGDU) PHARMACEUTICAL CO., LTD.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month